Summary
Cadila Pharmaceuticals Ltd (Cadila Pharmaceuticals) is a pharmaceutical company that develops, manufactures and markets branded generic formulations. The company’s product portfolio includes active pharmaceutical ingridients (APIs) and pharmaceutical formulations. It offers products in the form of capsules, tablets, orals, soft and hard gelatin capsules, and liquids. Cadila Pharma provides contract research and contract manufacturing services. The company offer products with therapeutic focus on gastrointestinal, cardiovascular, anti-infectives and antibiotics, analgesics, haematinics, respiratory agents, immunologicals, oncology and antidiabetics among others. Cadila Pharma works in partnership with academic and research-based organizations globally. The company has operations in Kenya, Nigeria, Ethiopia, the UK, Russia, the US, Sweden and Japan. Cadila Pharmaceuticals is headquartered in Ahmedabad, Gujarat, India.
Cadila Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cadila Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Oncology Venture Enters into Co-Development Agreement with Cadila Pharma 11
Lipidor Enters into Agreement with Cadila Pharma 11
Axelar Enters into Co-Development Agreement with Cadila Pharma 12
NovaSAID Enters Into Co-Development Agreement With Cadila Pharma 13
Pergamum And Cadila Pharma Partner To Develop Novel Antibiotics For Infections 14
Licensing Agreements 15
Cadila Pharma Enters into Licensing Agreement with Moberg Pharma 15
Cadila Pharma Enters Into Licensing Agreement With Helperby Therapeutics 16
Cadila Pharmaceuticals Ltd - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21
List of Tables
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts 1
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cadila Pharmaceuticals Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Cadila Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Oncology Venture Enters into Co-Development Agreement with Cadila Pharma 11
Lipidor Enters into Agreement with Cadila Pharma 11
Axelar Enters into Co-Development Agreement with Cadila Pharma 12
NovaSAID Enters Into Co-Development Agreement With Cadila Pharma 13
Pergamum And Cadila Pharma Partner To Develop Novel Antibiotics For Infections 14
Cadila Pharma Enters into Licensing Agreement with Moberg Pharma 15
Cadila Pharma Enters Into Licensing Agreement With Helperby Therapeutics 16
Cadila Pharmaceuticals Ltd, Key Competitors 17
Cadila Pharmaceuticals Ltd, Key Employees 18
Cadila Pharmaceuticals Ltd, Other Locations 19
Cadila Pharmaceuticals Ltd, Subsidiaries 19
List of Figures
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cadila Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9